O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?

Detalhes bibliográficos
Autor(a) principal: Dall'Oglio, Marcos Francisco [UNIFESP]
Data de Publicação: 2003
Outros Autores: Srougi, Miguel [UNIFESP], Nesrallah, Luciano [UNIFESP], Leite, Kátia Ramos Moreira [UNIFESP], Hering, Flávio [UNIFESP], Bomfim, Alexandre de Campos [UNIFESP], Sanudo, Adriana [UNIFESP]
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S0104-42302003000100039
http://repositorio.unifesp.br/handle/11600/1597
Resumo: OBJECTIVE: The behavior of the renal cells carcinoma stage PT1 is not completely clarified. We studied the presence of factors after prognostics and tumoral size in the recurrence of survival of the sporadic kidney carcinoma after surgical treatment. METHODS: 120 patients followed after nephrectomy had been revised retrospectively 93 PT1, 9 PT2, 11 PT3, 7 PT4, It was analyzed survival and recurrence of the disease inside of three groups of tumors: Group 1: < 4cm, group 2: 4-7cm and group 3: > 7cm, and the prognostics factors above-mentioned evaluated were nuclear degree, microvascular invasion, presence of committed ganglia and sarcomatous degeneration. RESULTS: The frequency of adverse prognostics factors increase as the tumor size increase. In the group 1, we had only four tumors of high degree and only one shown microvascular invasion that does not committed ganglia or sarcomatous degeneration. In group 2 there was 16 tumors of high degree, 4 sarcomatoses, two with positive microvascular invasion and two with positive ganglia. In group 3, was found 18 tumors of high degree, 15 with microvascular invasion and 7 with positive ganglia and 5 sarcomatoses. There was statistical significance in the specific cancer survival (p=0.002) and free of illness (p=0.0002) between the three groups. CONCLUSION: The evolution of tumors PT1 is distinct for lesser tumors of 4 cm and 4-7 cm fitting the subdivision of these two groups in T1a and T1b.
id UFSP_b3a98c93f7381424808da4b72576182a
oai_identifier_str oai:repositorio.unifesp.br/:11600/1597
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?Must the TNM staging of the renal cell carcinoma be modified again?Carcinoma renal cellNeoplasm stagingNeoplasmsNeoplasm recurrenceTNM classificationCarcinoma de células renaisEstadiamentoNeoplasiasNeoplasia recorrenteOBJECTIVE: The behavior of the renal cells carcinoma stage PT1 is not completely clarified. We studied the presence of factors after prognostics and tumoral size in the recurrence of survival of the sporadic kidney carcinoma after surgical treatment. METHODS: 120 patients followed after nephrectomy had been revised retrospectively 93 PT1, 9 PT2, 11 PT3, 7 PT4, It was analyzed survival and recurrence of the disease inside of three groups of tumors: Group 1: < 4cm, group 2: 4-7cm and group 3: > 7cm, and the prognostics factors above-mentioned evaluated were nuclear degree, microvascular invasion, presence of committed ganglia and sarcomatous degeneration. RESULTS: The frequency of adverse prognostics factors increase as the tumor size increase. In the group 1, we had only four tumors of high degree and only one shown microvascular invasion that does not committed ganglia or sarcomatous degeneration. In group 2 there was 16 tumors of high degree, 4 sarcomatoses, two with positive microvascular invasion and two with positive ganglia. In group 3, was found 18 tumors of high degree, 15 with microvascular invasion and 7 with positive ganglia and 5 sarcomatoses. There was statistical significance in the specific cancer survival (p=0.002) and free of illness (p=0.0002) between the three groups. CONCLUSION: The evolution of tumors PT1 is distinct for lesser tumors of 4 cm and 4-7 cm fitting the subdivision of these two groups in T1a and T1b.OBJETIVOS: O comportamento do carcinoma de células renais estádio PT1 não está completamente esclarecido. Nós estudamos a presença de fatores prognósticos e tamanho tumoral na recorrência e sobrevida do carcinoma de rim esporádico após tratamento cirúrgico. MÉTODOS: Foram revisados retrospectivamente 120 pacientes, 93 PT1, nove PT2, 11 PT3, sete PT4, seguidos após nefrectomia. Foram analisadas sobrevida e recorrência da doença dentro de três grupos de tumores: grupo 1: < 4cm, grupo 2: 4-7 cm e grupo 3: >7 cm e os fatores prognósticos preditivos avaliados foram grau nuclear, invasão microvascular, presença de gânglios comprometidos e degeneração sarcomatosa RESULTADOS: A freqüência de fatores prognósticos adversos aumenta à medida que aumenta o tamanho do tumor. No grupo 1 tivemos apenas quatro tumores de alto grau e somente um apresentou invasão microvascular não havendo gânglios comprometidos ou degeneração sarcomatosa. No grupo 2 havia 16 tumores de alto grau, quatro sarcomatosos, dois com invasão microvascular positiva e dois com gânglios positivos. No grupo 3, encontraram-se 18 tumores de alto grau, 15 com invasão microvascular e sete com gânglios positivos e cinco sarcomatosos. Houve significância estatística na sobrevida câncer específica (p=0,002) e livre de doença (p=0,0002) entre os três grupos. CONCLUSÃO: A evolução dos tumores PT1 é distinta para tumores menores de 4 cm e de 4-7 cm cabendo a subdivisão destes dois grupos em T1a e T1b.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Departamento de UrologiaUNIFESP, EPM, Depto. de UrologiaSciELOAssociação Médica BrasileiraUniversidade Federal de São Paulo (UNIFESP)Dall'Oglio, Marcos Francisco [UNIFESP]Srougi, Miguel [UNIFESP]Nesrallah, Luciano [UNIFESP]Leite, Kátia Ramos Moreira [UNIFESP]Hering, Flávio [UNIFESP]Bomfim, Alexandre de Campos [UNIFESP]Sanudo, Adriana [UNIFESP]2015-06-14T13:29:52Z2015-06-14T13:29:52Z2003-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion86-90application/pdfhttp://dx.doi.org/10.1590/S0104-42302003000100039Revista da Associação Médica Brasileira. Associação Médica Brasileira, v. 49, n. 1, p. 86-90, 2003.10.1590/S0104-42302003000100039S0104-42302003000100039.pdf0104-4230S0104-42302003000100039http://repositorio.unifesp.br/handle/11600/1597porRevista da Associação Médica Brasileirainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-27T23:39:54Zoai:repositorio.unifesp.br/:11600/1597Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-27T23:39:54Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?
Must the TNM staging of the renal cell carcinoma be modified again?
title O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?
spellingShingle O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?
Dall'Oglio, Marcos Francisco [UNIFESP]
Carcinoma renal cell
Neoplasm staging
Neoplasms
Neoplasm recurrence
TNM classification
Carcinoma de células renais
Estadiamento
Neoplasias
Neoplasia recorrente
title_short O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?
title_full O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?
title_fullStr O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?
title_full_unstemmed O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?
title_sort O estadiamento TNM do carcinoma de células renais deve ser modificado novamente ?
author Dall'Oglio, Marcos Francisco [UNIFESP]
author_facet Dall'Oglio, Marcos Francisco [UNIFESP]
Srougi, Miguel [UNIFESP]
Nesrallah, Luciano [UNIFESP]
Leite, Kátia Ramos Moreira [UNIFESP]
Hering, Flávio [UNIFESP]
Bomfim, Alexandre de Campos [UNIFESP]
Sanudo, Adriana [UNIFESP]
author_role author
author2 Srougi, Miguel [UNIFESP]
Nesrallah, Luciano [UNIFESP]
Leite, Kátia Ramos Moreira [UNIFESP]
Hering, Flávio [UNIFESP]
Bomfim, Alexandre de Campos [UNIFESP]
Sanudo, Adriana [UNIFESP]
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Dall'Oglio, Marcos Francisco [UNIFESP]
Srougi, Miguel [UNIFESP]
Nesrallah, Luciano [UNIFESP]
Leite, Kátia Ramos Moreira [UNIFESP]
Hering, Flávio [UNIFESP]
Bomfim, Alexandre de Campos [UNIFESP]
Sanudo, Adriana [UNIFESP]
dc.subject.por.fl_str_mv Carcinoma renal cell
Neoplasm staging
Neoplasms
Neoplasm recurrence
TNM classification
Carcinoma de células renais
Estadiamento
Neoplasias
Neoplasia recorrente
topic Carcinoma renal cell
Neoplasm staging
Neoplasms
Neoplasm recurrence
TNM classification
Carcinoma de células renais
Estadiamento
Neoplasias
Neoplasia recorrente
description OBJECTIVE: The behavior of the renal cells carcinoma stage PT1 is not completely clarified. We studied the presence of factors after prognostics and tumoral size in the recurrence of survival of the sporadic kidney carcinoma after surgical treatment. METHODS: 120 patients followed after nephrectomy had been revised retrospectively 93 PT1, 9 PT2, 11 PT3, 7 PT4, It was analyzed survival and recurrence of the disease inside of three groups of tumors: Group 1: < 4cm, group 2: 4-7cm and group 3: > 7cm, and the prognostics factors above-mentioned evaluated were nuclear degree, microvascular invasion, presence of committed ganglia and sarcomatous degeneration. RESULTS: The frequency of adverse prognostics factors increase as the tumor size increase. In the group 1, we had only four tumors of high degree and only one shown microvascular invasion that does not committed ganglia or sarcomatous degeneration. In group 2 there was 16 tumors of high degree, 4 sarcomatoses, two with positive microvascular invasion and two with positive ganglia. In group 3, was found 18 tumors of high degree, 15 with microvascular invasion and 7 with positive ganglia and 5 sarcomatoses. There was statistical significance in the specific cancer survival (p=0.002) and free of illness (p=0.0002) between the three groups. CONCLUSION: The evolution of tumors PT1 is distinct for lesser tumors of 4 cm and 4-7 cm fitting the subdivision of these two groups in T1a and T1b.
publishDate 2003
dc.date.none.fl_str_mv 2003-01-01
2015-06-14T13:29:52Z
2015-06-14T13:29:52Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0104-42302003000100039
Revista da Associação Médica Brasileira. Associação Médica Brasileira, v. 49, n. 1, p. 86-90, 2003.
10.1590/S0104-42302003000100039
S0104-42302003000100039.pdf
0104-4230
S0104-42302003000100039
http://repositorio.unifesp.br/handle/11600/1597
url http://dx.doi.org/10.1590/S0104-42302003000100039
http://repositorio.unifesp.br/handle/11600/1597
identifier_str_mv Revista da Associação Médica Brasileira. Associação Médica Brasileira, v. 49, n. 1, p. 86-90, 2003.
10.1590/S0104-42302003000100039
S0104-42302003000100039.pdf
0104-4230
S0104-42302003000100039
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Revista da Associação Médica Brasileira
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 86-90
application/pdf
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268277419933696